So, Ceritinib is this ALK inhibitor that’s made specifically to help with ALK-positive metastatic non-small cell lung cancer, or NSCLC for short. It does its thing by focusing on the ALK signaling pathway. You can get it as capsules, each with 150 mg of the main stuff.
For adults, the go-to dose is 450 mg once a day, and it’s best to take it with food. They come in bottles, each with 70 capsules. The key part in this drug goes straight for the ALK protein, which a lot of lung cancer cells have when they’ve spread to other areas.
Ceritinib is just the generic version of Xalkori, which is the brand name. It’s used for the same thing as Xalkori, which is treating ALK-positive NSCLC. It’s super important to stick with the dosing they tell you to, so you get the most benefit and the least side effects.
